Table 14 (abstract P24). Clinical characteristics and laboratory findings of M694V homozygote patients

Age of diagnosis (years),

5 (0-17)

4 (1-15)

0,098^*

Disease duration (years),

6 (0-17)

7 (1-17)

0,004^*

Attack status in last 6 months, n (%)

72 (30,0)

65 (47,1)

0,001^**

Attacks frequency in last 6 months

2 (1-19)

2 (1-15)

0,722^*

Disease activity score

0 (0-5)

1 (0-6)

<0,001^*

AIDAI,

0 (0-14)

1 (0-9)

<0,001^*

Regular drug use (n = 192), n (%)

86 (64,7)

38 (64,4)

0,973^**

Need for addditional treatment (n = 192), n (%)

7 (5,3)

13 (22,0)

<0,001^**